Pulmonary Disease, Chronic Obstructive Clinical Trial
Official title:
COPD Online Rehabilitation (CORe) - a Randomized, Multicenter Telemedicine Intervention Study
International and national publications emphasize that COPD rehabilitation is a key
cornerstone in the standard treatment of COPD, based on more than 15 years of research in
COPD rehabilitation. COPD rehabilitation improves quality of life, anxiety and depression and
physical function. COPD rehabilitation including special physical training, patient-directed
education and smoking cessation is core rehabilitation elements, which today are recommended
as mandatory content in standard COPD rehabilitation.
Standard COPD rehabilitation is an established offer in all regions and municipalities in
Denmark. It is however a well-known challenge, that persons with the most severe COPD
symptoms and co-morbidities are most likely not to receive COPD rehabilitation. Frequent
exacerbations, socially isolation, transport distance to rehabilitation are main reasons why
people with severe COPD disease deliberately chooses not to receive COPD rehabilitation. Why
there at present are no rehabilitation alternatives for patients with the most severe COPD
symptoms, supervised COPD Online rehabilitation in groups, delivered by health professionals
in the COPD patients' own home via a computer screen could likely encourage more people to
participate. The number of RCT's investigating the effect of supervised Online delivered COPD
rehabilitation in groups versus established COPD rehabilitation are very limited.
The purpose of this randomized study is to investigate the short-term and long-term efficacy
of 10 weeks of online COPD rehabilitation versus conventional supervised COPD rehabilitation
in people with severe and very severe COPD. The outcome of the intervention is measured on
walking distance, muscle endurance, activity level, quality of life and COPD symptoms
respectively. Outcomes are measures before intervention start, end of intervention. This
study also collects follow-up update after 3, 6 and 12 month. The follow-up data will be in
separate publication.
Hypothesis
1. COPD online rehabilitation provides significant larger improvements than the usual care
on walking distance, muscle endurance, activity level, and quality of life and COPD
symptoms in people with severe and very severe COPD.
2. COPD online rehabilitation and conventional COPD rehabilitation, provides clinically
relevant improvement on walking distance, muscle endurance, activity level, quality of
life and COPD symptoms in people with severe and very severe COPD.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
| Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
| Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
| Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
| Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
| Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
| Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
| Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
| Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
| Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
| Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
| Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
| Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
| Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
| Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
| Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|